BI
BioPorto A/S
BIOPOR.CO · CPH
1.20 kr +0.00% (+0.00 kr)
1M +6.19%
Market Cap 591.6M kr
P/E Ratio -
Div. Yield -
ROE 138.11%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 9.39x
P/S 14.69x
EV/FFO N/A
Growth
58 /100
Stable Book val. growth 3.55%
Rev. growth 11.62%
FCF growth N/A
Profitability
20 /100
Weak Net margin 203.83%
Op. margin 213.70%
FCF margin 191.29%
Quality
5 /100
Poor ROE 138.11%
ROA 88.13%
Asset turnover 0.43x
Debt
69 /100
Low Current ratio 3.25x
Int. coverage -111.52x
Debt/Equity 0.12x
Stability
69 /100
Stable Rev. volatility 5.12%
EPS volatility 18.34%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOPOR.CO
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Carsten Buhl
Employees
46
Headquarters
Hellerup
Evenimente viitoare
19 NOV.
Earnings
Upcoming earnings report